{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:16:08Z","timestamp":1790111768294,"version":"4.0.1"},"reference-count":52,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Herpes simplex virus type 2 (HSV-2) is the causative pathogen of genital herpes and is closely associated with the occurrence of cervical cancer and human immunodeficiency virus (HIV) infection. The absence of an effective vaccine and the emergence of drug resistance to commonly used nucleoside analogs emphasize the urgent need for alternative antivirals against HSV-2. Recently, ABMA [1-adamantyl (5-bromo-2-methoxybenzyl) amine] has been demonstrated to be an inhibitor of several pathogens exploiting host-vesicle transport, which also participates in the HSV-2 lifecycle. Here, we showed that ABMA inhibited HSV-2-induced cytopathic effects and plaque formation with 50% effective concentrations of 1.66 and 1.08 \u03bcM, respectively. We also preliminarily demonstrated in a time of compound addition assay that ABMA exerted a dual antiviral mechanism by impairing virus entry, as well as the late stages of the HSV-2 lifecycle. Furthermore, in vivo studies showed that ABMA protected BALB\/c mice from intravaginal HSV-2 challenge with an improved survival rate of 50% at 5 mg\/kg (8.33% for the untreated virus infected control). Consequently, our study has identified ABMA as an effective inhibitor of HSV-2, both in vitro and in vivo, for the first time and presents an alternative to nucleoside analogs for HSV-2 infection treatment.<\/jats:p>","DOI":"10.3390\/v10030119","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T12:17:41Z","timestamp":1520597861000},"page":"119","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo"],"prefix":"10.3390","volume":"10","author":[{"given":"Wenwen","family":"Dai","sequence":"first","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[{"name":"SIMOPRO, CEA, Universit\u00e9 Paris-Saclay, F-91191 Gif Sur Yvette, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Bi","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, Jilin, China"},{"name":"Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-4973","authenticated-orcid":false,"given":"Julien","family":"Barbier","sequence":"additional","affiliation":[{"name":"SIMOPRO, CEA, Universit\u00e9 Paris-Saclay, F-91191 Gif Sur Yvette, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5758-8077","authenticated-orcid":false,"given":"Jean-Christophe","family":"Cintrat","sequence":"additional","affiliation":[{"name":"SIMOPRO, CEA, Universit\u00e9 Paris-Saclay, F-91191 Gif Sur Yvette, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, Jilin, China"},{"name":"Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0477-3599","authenticated-orcid":false,"given":"Daniel","family":"Gillet","sequence":"additional","affiliation":[{"name":"SIMOPRO, CEA, Universit\u00e9 Paris-Saclay, F-91191 Gif Sur Yvette, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiheng","family":"Su","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, Jilin, China"},{"name":"Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlai","family":"Jiang","sequence":"additional","affiliation":[{"name":"National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, Jilin, China"},{"name":"Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"ref_1","first-page":"883","article-title":"Sexually transmitted diseases of alpha herpes virus in women","volume":"58","author":"Kawana","year":"2000","journal-title":"Nihon Rinsho Jpn. J. Clin. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"958","DOI":"10.7326\/0003-4819-98-6-958","article-title":"Genital herpes simplex virus infections: Clinical manifestations, course, and complications","volume":"98","author":"Corey","year":"1983","journal-title":"Ann. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(07)61908-4","article-title":"Genital herpes","volume":"370","author":"Gupta","year":"2007","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/aje\/kwf098","article-title":"Herpes simplex virus and risk of cervical cancer: A longitudinal, nested case-control study in the Nordic countries","volume":"156","author":"Lehtinen","year":"2002","journal-title":"Am. J. Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/338231","article-title":"Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis","volume":"185","author":"Wald","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_6","first-page":"36A","article-title":"The interaction between herpes simplex virus and human immunodeficiency virus","volume":"11","author":"Celum","year":"2004","journal-title":"Herpes J. IHMF"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Looker, K., Magaret, A., Turner, K., Vickerman, P., Gottlieb, S., and Newman, L. (2015). Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128615"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1172\/JCI57148","article-title":"HSV-2: In pursuit of a vaccine","volume":"121","author":"Johnston","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/sti.75.1.49","article-title":"Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2","volume":"75","author":"White","year":"1999","journal-title":"Sex. Trans. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CMR.16.1.114-128.2003","article-title":"Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy","volume":"16","author":"Bacon","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_11","first-page":"460","article-title":"Acute renal failure and neurotoxicity following oral acyclovir","volume":"28","author":"Johnson","year":"1994","journal-title":"Ann. Pharm."},{"key":"ref_12","first-page":"111","article-title":"Acyclovir- and ganciclovir-induced neurotoxicity","volume":"32","author":"Ernst","year":"1998","journal-title":"Ann. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/QCO.0000000000000211","article-title":"Herpes simplex virus and varicella zoster virus: Recent advances in therapy","volume":"28","author":"De","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_14","first-page":"CS75","article-title":"Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children","volume":"11","author":"Khurana","year":"2005","journal-title":"Med. Sci. Monit."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15567","DOI":"10.1038\/s41598-017-15466-7","article-title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.gt.3302525","article-title":"Delivery into cells: Lessons learned from plant and bacterial toxins","volume":"12","author":"Sandvig","year":"2005","journal-title":"Gene Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/tra.12389","article-title":"Fusion of Enveloped Viruses in Endosomes","volume":"17","author":"White","year":"2016","journal-title":"Traffic"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/febs.13601","article-title":"Leishmania hijacking of the macrophage intracellular compartments","volume":"283","author":"Loiseau","year":"2016","journal-title":"Febs J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.antiviral.2003.09.006","article-title":"Treatment of herpes simplex virus infections","volume":"61","author":"Brady","year":"2004","journal-title":"Antivir. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: An old drug against today\u2019s diseases?","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1083\/jcb.200204010","article-title":"Selective internalization of sodium channels in rat dorsal root ganglion neurons infected with herpes simplex virus-1","volume":"158","author":"Storey","year":"2002","journal-title":"J. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1128\/JVI.75.3.1236-1251.2001","article-title":"Characterization of herpes simplex virus-containing organelles by subcellular fractionation: Role for organelle acidification in assembly of infectious particles","volume":"75","author":"Harley","year":"2001","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2015.06.005","article-title":"Broad-spectrum non-nucleoside inhibitors of human herpesviruses","volume":"121","author":"McClain","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1084\/jem.20030162","article-title":"Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells","volume":"198","author":"Lund","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-1759(93)90011-U","article-title":"The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity","volume":"160","author":"Crouch","year":"1993","journal-title":"J. Immunol. Methods"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jnci\/81.8.577","article-title":"New soluble-formazan assay for HIV-1 cytopathic effects: Application to high-flux screening of synthetic and natural products for AIDS-antiviral activity","volume":"81","author":"Weislow","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.coviro.2011.06.003","article-title":"Herpesvirus capsid assembly: Insights from structural analysis","volume":"1","author":"Brown","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0166-3542(01)00207-8","article-title":"Inhibition of herpes simplex virus type 2 (HSV-2) viral replication by the dominant negative mutant polypeptide of HSV-1 origin binding protein","volume":"53","author":"Yao","year":"2002","journal-title":"Antivir. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00705-015-2514-z","article-title":"Antiherpes evaluation of soybean isoflavonoids","volume":"160","author":"Argenta","year":"2015","journal-title":"Arch. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1128\/JVI.00636-15","article-title":"Dynasore Disrupts Trafficking of Herpes Simplex Virus Proteins","volume":"89","author":"Mues","year":"2015","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1023\/A:1016499810146","article-title":"Efficacy of 5-vinyl-1-beta-d-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: Comparison with acyclovir and foscarnet","volume":"4","author":"Reefschlager","year":"1987","journal-title":"Pharm. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.antiviral.2012.01.003","article-title":"Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice","volume":"93","author":"Shestakov","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s11596-011-0685-8","article-title":"The anti-HSV-2 effect of alumen: In vitro and in vivo experimental studies","volume":"31","author":"Hong","year":"2011","journal-title":"J. Huazhong Univ. Sci. Technol.-Med. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"259103","DOI":"10.1093\/ecam\/nep157","article-title":"Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles","volume":"2011","author":"Cheng","year":"2011","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/v5061447","article-title":"Exploiting Herpes Simplex Virus Entry for Novel Therapeutics","volume":"5","author":"Hadigal","year":"2013","journal-title":"Viruses"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0168-1702(88)90023-8","article-title":"Quantitative studies on the maturation process of herpes simplex virus type 1 in Vero cells","volume":"10","author":"Koyama","year":"1988","journal-title":"Virus Res."},{"key":"ref_37","first-page":"369","article-title":"A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2","volume":"70","author":"Parr","year":"1994","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jviromet.2013.02.006","article-title":"An improved system for the evaluation of antiviral compounds against herpes simplex virus type 2","volume":"189","author":"Yin","year":"2013","journal-title":"J. Virol. Methods"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1128\/JVI.02243-12","article-title":"Antiviral Activity of Trappin-2 and Elafin In Vitro and In Vivo against Genital Herpes","volume":"87","author":"Drannik","year":"2013","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1248\/cpb.33.3881","article-title":"Antiviral activity of natural occurring flavonoids in vitro","volume":"33","author":"Tsuchiya","year":"1985","journal-title":"Chem. Pharm. Bull."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0166-3542(02)00054-2","article-title":"Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication","volume":"55","author":"Gong","year":"2002","journal-title":"Antivir. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.antiviral.2009.06.007","article-title":"Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus","volume":"83","author":"Harden","year":"2009","journal-title":"Antivir. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2217\/fvl.15.85","article-title":"Cell entry mechanisms of HSV: What we have learned in recent years","volume":"10","author":"Agelidis","year":"2015","journal-title":"Future Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1111\/j.1742-4658.2009.07402.x","article-title":"Viral entry mechanisms: Cellular and viral mediators of herpes simplex virus entry","volume":"276","author":"Akhtar","year":"2009","journal-title":"Febs J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1043661802001706","article-title":"The memory effect of heteropolyoxotungstate (PM-19) pretreatment on infection by herpes simplex virus at the penetration stage","volume":"46","author":"Dan","year":"2002","journal-title":"Pharmacol. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1128\/JVI.03790-13","article-title":"Nelfinavir Inhibits Maturation and Export of Herpes Simplex Virus 1","volume":"88","author":"Kalu","year":"2014","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.3390\/v7092861","article-title":"Tegument Assembly and Secondary Envelopment of Alphaherpesviruses","volume":"7","author":"Owen","year":"2015","journal-title":"Viruses"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1128\/JVI.00463-12","article-title":"Replication of Herpes Simplex Virus: Egress of Progeny Virus at Specialized Cell Membrane Sites","volume":"86","author":"Mingo","year":"2012","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/JVI.75.8.3675-3684.2001","article-title":"Egress of alphaherpesviruses: Comparative ultrastructural study","volume":"75","author":"Granzow","year":"2001","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1513\/pats.200504-037SR","article-title":"Pharmacologic principles for combination therapy","volume":"2","author":"Toews","year":"2005","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/QCO.0000000000000015","article-title":"Herpes simplex virus drug-resistance: New mutations and insights","volume":"26","author":"Andrei","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aaa3778","article-title":"Combating emerging viral threats","volume":"348","author":"Bekerman","year":"2015","journal-title":"Science"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/3\/119\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:56:26Z","timestamp":1760194586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/3\/119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3]]}},"alternative-id":["v10030119"],"URL":"https:\/\/doi.org\/10.3390\/v10030119","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]}}}